Article
Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis
25 Jun 2022
Abstract excerpt
Given the discontinuation of various first-line drugs for visceral leishmaniasis (VL), large-scale in vivo drug screening, establishment of a relapse model in rodents, immunophenotyping, and transcriptomics were combined to study persistent infections and therapeutic failure. Double bioluminescent/fluorescent Leishmania infantum and L. donovani reporter lines enabled the identification of long-term hematopoietic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
